Physician
Cardiology
Dr. Lameh Fananapazir, MD
|
|
Give Review
Lameh Fananapazir practices Cardiology. Lameh Fananapazir is also published. He has 91 publications published. The lastest publication: "Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains.' Lameh Fananapazir accepts Medicare payments and is listed with Medicare.gov.
Publications
- Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illness.
- Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
- The possible relation between late pregnancy hypertension and 5-hydroxytryptamine levels in maternal blood.
- Suppression of incessant ventricular tachycardia in hypertrophic Cardiomyopathy associated with improvement of severe left ventricular dysfunction.
- Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic Cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker ther...
- Altered cardiac hemodynamic and electrical state in normal sinus rhythm after Chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertr...
- Prognostic determinants in hypertrophic Cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiologic...
- Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic Cardiomyopathy.
- Differences in clinical expression of hypertrophic Cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation ...
- Sudden cardiac death in hypertrophic Cardiomyopathy.
- Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with Hypertrophic car...
- Evidence of genetic heterogeneity in five kindreds with familial hypertrophic Cardiomyopathy.
- Sudden death during empiric amiodarone therapy in symptomatic hypertrophic Cardiomyopathy.
- Value of electrophysiologic studies in hypertrophic Cardiomyopathy treated with amiodarone.
- Hemodynamic and electrophysiologic evaluation of patients with hypertrophic Cardiomyopathy surviving cardiac arrest.
- Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic Cardiomyopathy.
- Effect of intravenous magnesium sulfate on blood magnesium parameters.
- Abnormal cardiac sensitivity in patients with chest pain and normal Coronary arteries.
- Importance of preexcited QRS morphology during induced Atrial fibrillation to the diagnosis and localization of multiple accessory pathways.
- Genetic evidence of dissociation (generational skips) of electrical from morphologic forms of hypertrophic Cardiomyopathy.
- Reliability of the evoked response in determining the paced ventricular rate and performance of the QT or rate responsive (TX) pacemaker.
- Long-term follow-up of patients with the QT rate adaptive pacemaker.
- Comparison of vitreous carbon and elgiloy transvenous ventricular pacing leads.
- VT and sudden death in HCM patients.
- Electrophysiologic abnormalities in patients with hypertrophic Cardiomyopathy. A consecutive analysis in 155 patients.
- Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death.
- Wolff-Parkinson-White syndrome and sudden cardiac death.
- Ventricular septal defect after myocardial infarction: assessment by cross sectional echocardiography with pulsed wave Doppler scanning.
- Echocardiographic detection of perforation of the cardiac ventricular septum by a permanent pacemaker lead.
- Comparison of oxyfedrine and atenolol in Angina pectoris--a double-blind study.
- Urinary beta-thromboglobulin in essential hypertension.
- Comparison of resting hemodynamic indices and exercise performance during Atrial synchronized and asynchronous ventricular pacing.
- Atrial synchronized ventricular pacing: contribution of the chronotropic response to improved exercise performance.
- Experience with 407 transvenous, finned pacing leads with a sintered porous-surfaced electrode.
- Results of Valve replacement with the Omniscience prosthesis.
- Right ventricular dysfunction and surgical outcome in postinfarction ventricular septal defect.
- Contribution of Heart rate to QT interval shortening during exercise.
- Comparison of single and divided daily dose spironolactone in the control of hypertension.
- Regression of multiple pulmonary varices after mitral Valve replacement.
- Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systems.
- Relief of left ventricular outflow tract obstruction following inadvertent left ventricular apical pacing in a patient with hypertrophic Cardiomyopathy.
- Prevalence of hypertrophic Cardiomyopathy and limitations of screening methods.
- Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic Cardiomyopathy.
- Identification of patients with hypertrophic Cardiomyopathy at high risk for sudden death.
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic Cardiomyopathy.
- Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic Cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reducti...
- Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic Cardiomyopathy.
- Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic Cardiomyopathy.
- Genotype-phenotype correlations in hypertrophic Cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene m...
- Missense mutations in the beta-myosin heavy-chain gene cause central core Disease in hypertrophic cardiomyopathy.
- Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic Cardiomyopathy.
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human Heart and skeletal muscle.
- Differential effects of changes in local myocardial refractoriness on Atrial and ventricular latency.
- A Fourier based algorithm for tracking SPAMM tags in gated magnetic resonance cardiac images.
- Hypertrophic Cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.
- The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic Cardiomyopathy.
- Hypertrophic obstructive Cardiomyopathy: problems of management.
- Therapeutic options in patients with obstructive hypertrophic Cardiomyopathy and severe drug-refractory symptoms.
- Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains.
- Advances in molecular genetics and management of hypertrophic Cardiomyopathy.
- Myocardial bridging in children with hypertrophic Cardiomyopathy.
- Temporal repolarization lability in hypertrophic Cardiomyopathy caused by beta-myosin heavy-chain gene mutations.
- Myocardial perfusion and sympathetic innervation in patients with hypertrophic Cardiomyopathy.
- Inherited and de novo mutations in the cardiac actin gene cause hypertrophic Cardiomyopathy.
- Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac Disease.
- Hypertrophic Cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnorm...
- R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic Cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
- Advances in understanding hypertrophic Cardiomyopathy.
- Identification of a gene responsible for Familial Wolff-Parkinson-White syndrome.
- Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic Cardiomyopathy.
- Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis.
- Novel association of hypertrophic Cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6).
- Chorein detection for the diagnosis of chorea-acanthocytosis.
- Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.
- Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.
- Obstructive hypertrophic Cardiomyopathy.
- Early clinical heterogeneity in choreoacanthocytosis.
- Modification of human hearing loss by plasma-membrane calcium pump PMCA2.
- Left Atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy.
- Is functional capacity related to left Atrial contractile function in nonobstructive hypertrophic cardiomyopathy?
- Ventilatory efficiency and resting hemodynamics in hypertrophic Cardiomyopathy.
- Long-term follow-up of children and adolescents diagnosed with hypertrophic Cardiomyopathy: risk factors for adverse arrhythmic events.
- Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic Cardiomyopathy.
- Mutations of MYO6 are associated with recessive deafness, DFNB37.
- Genomic organization, alternative splicing, and expression of human and mouse N-RAP, a nebulin-related LIM protein of striated muscle.
- Utility of genetic screening in hypertrophic Cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations.
- Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic Cardiomyopathy.
- Assessment of regional systolic and diastolic dysfunction in familial hypertrophic Cardiomyopathy using MR tagging.
- Myocardial bridging in adult and pediatric patients with hypertrophic Cardiomyopathy is not associated with poor outcome.
- Microarray gene expression profiles in dilated and Hypertrophic cardiomyopathic end-stage heart failure.
Schools
University Of Edinburgh
Royal Infir Edinburgh
Western Genl HospU Edinburgh
Duke University Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardioversion, Elective
- View All
Conditions Treated
- Angina
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomyopathy
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Education
-
Duke University Hospital
Drug Facts
| NPI NUMBER | 1568409415 | |
| NPPES Provider LastName | FANANAPAZIR | |
| NPPES Provider FirstName | LAMEH | |
| NPPES Provider ZIPCode | 215026567 | |
| NPPES Provider State | MD | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1131.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568409415 |
| Last Name Of The Provider | FANANAPAZIR |
| First Name Of The Provider | LAMEH |
| View All |
Similar Doctors
|
|
Dr. Suresh M. Shrestha, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Baljeet S. Mahal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pradeep K. Kulkarni, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher Haas, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter B. Halmos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Narayan P. Saheta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clarence J. Vincent, MD
This Doctor is OpenDoctor Recommended.
|